Covid-19 vaccine authorization for younger children delayed as FDA seeks more data

Parents continue to wait to find out when their youngest children are able to get a Covid-19 vaccine. Pfizer and BioNTech have submitted a request to the FDA to authorize the use of their drug in people 6 months to 5 years old. The meeting that was originally scheduled for February 15, 2022 has been postponed due to new data. New data shows that while the vaccine is safe, it lacks true effectiveness. The FDA is requesting data from an ongoing trial of a third vaccine dose which is not scheduled to be completed until April 2022. This delay in authorization is not a “no,” more trials are needed in order to keep everyone safe.

To learn more, click here.